Uluslararası Yayınlar

Prof.Dr. Salih Emri’nin “uluslararası yayın” niteliğinde toplam 124 adet yayını vardır.
a) SCI,SCI-EXP kapsamındaki dergilerde toplam 37 adet makalesi vardır. Bu grupta “Simian vİrus 40 is not a Cofactor in the Pathogenesİs of Environmentally Induced Malİgnant Pleural Mesothelioma in Turkey” başlıklı yayını başlıca araştırma eseri olup, Anticancer Research dergisinde 2000 yılında yayınlanmıştır. Bu çalışmada Türkiye’de çevresel mineral lif temasına sekonder gelişmiş mezotelyoma dokularında SV40 virüsünün DNA sekansları bir TUBITAK projesi çerçevesinde araştırılmış ve bu virüsün Batı Ülkelerinin aksine Türkiye’de mezotelyoma patogenezinde bir kofaktör olmadığı sonucuna varılmıştır. Bu gruptaki yayınlarının 1’i hariç hepsi doçentlik sonrası döneme aittir.

1. Taşdemir I, Sivri B, Turgan Ç, Emri S, Yasavul U, and Çağlar Ş. The expanding
spectrum of a disease. Behçet’s disease associated with amyloidosis. Nephron 1989;
52: 154-157.

2. Selçuk ZT, Çöplü L, Emri S, Kalyoncu AF, Şahin AA, Barış Yİ. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey.
Analysis of 135 cases. Chest 1992; 102: 790-796.

3. Akhan O, Demirkazık FB, Özmen MN, Balkancı F, Özkara Ş, Çöplü L, Emri
S, and Besim A. Tuberculous pleural effusions: Ultrasonic diagnosis. J Clin Ultrasound 1992; 20: 461-465.

4. Şahin AA, Çöplü L, Selçuk ZT , Eryılmaz M, Emri S, Akhan O, Barış Yİ. Malignant pleural mesothelioma caused by environmental exposure to asbestos or erionite in rural Turkey:CT findings in 84 patients. AJR 1993; 161: 533-537.

5. Tansan T, Emri S, Selçuk T, Koç Y, Hesketh P, Heeren T, McCaffrey RP, and Barış Yİ. Treatment of Malignant Pleural Mesothelioma with Cisplatin, Mitomycin C and Alpha Interferon. Oncology 1994; 51: 348-351.

6. Kalyoncu AF, Selçuk ZT, Karakoca Y, Emri AS, Çöplü L, Şahin AA, and Barış Yİ.
Prevalence of childhood asthma and allergic disease in Ankara. Allergy 1994; 49: 485-488.

7. Idell S, Pueblitz S, Emri S, Güngen Y, Gray L, Kumar A, Holiday D, Koenig KB, and
Johnson AR. Regulation of Fibrin Deposition by Malignant Mesothelioma. Am J Pathol 1995; 147: 1318-1329.

8. Kalyoncu AF, Çöplü L, Selçuk ZT, Emri AS, Kolaçan B, Kocabaş A, Akkoçlu A, Erkan L, Şahin AA, and Barış Yi. Survey on the allerjik status of patients with bronchial asthma in Turkey: A multicenter study. Allergy 1995; 50: 451-455.

9. Shetty S, Kumar A, Pueblitz S, Emri S, Gungen Y, Johnson AR, and Idell S. Fibrinogen Promotes Adhesion of Monocytic to Human Mesothelioma Cells. Thromb Haemost 1996; 75: 782-790.

10. Özdemir O, Emri S, Karakoca Y, Sayınalp N, Akay H, Dündar S, and Barış Yİ. Fibrinolytic System in Plasma and Pleural Fluid in Malignant Pleural Mesothelioma. Thromb Res 1996; 84:121-128.

11. Kostakoglu L, Kıratlı P, Ruacan S, Hayran M, Emri S, Ergün EL, Bekdik CF.
Association of tumor washout rates and accumulation of technetium-99m-MIBI
with expression of P-glycoprotein in lung cancer. J Nucl Med 1988; 39: 228-234.

12. Dumortier P, Coplu L, Maertelaer V, Emri S, Barıi I, Vuyst PD. Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 1998; 158: 1815-1824.

13. Emri S, Bagcı T, Karakoca Y, Barış E. Recognition of cigarette brand names and logos by primary school children in Ankara. Tobacco Control 1998;7: 386-392.

14. Emri S, Kocagöz T, Olut A, Güngen Y, Mutti L, Baris YI. Simian virus 40 is not a cofactor in the pathogenesis of environmentally induced malignant pleural mesothelioma in Turkey. Anticancer Research 2000; 20: 891-894.

15. Atimtay AT, Emri S, Bagci T, Demir AU. Urban CO exposure and its health efects on traffic policemen in Ankara. Environmental Research 2000; 82: 222-230.

16. Emri S, Akbulut H, Zorlu F, Dinçol D, Akay H, Güngen Y, Icli F. Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer. 2001; 33: 109-114.

17. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001;357:444-445.

18. Olut A, Firat P, Ertugrul D, Gungen Y, Emri S.Ras oncoprotein expression in erionite -and asbestos-induced Turkish malignancy pleural mesothelioma-a pilot study. Respiratory Medicine 2001;95:697-698.

19. Dumortier P, Coplu L, Broucke I, Emri S, Selcuk T, de Maertelaer V, De Vuyst P, Baris I.Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzkoy, Cappadocia, Turkey. Occup Environ Med 2001;58:261-266.

20. Jasani B, Cristaudo A, Emri SA, Gazdar AF, Gibbs A, Krynska B, Miller C, Mutti L, Radu C, Tognon M, Procopio A. Association of SV40 with human tumours.
Semin Cancer Biol 2001;11: 49-61. Review.
21. Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicology Letters 2002;127: 251-257. Review.

22. Tomek S, Emri S, Krejcy K, Manegold C. Chemotherapy for malignant pleural mesothelioma: past results and recent developments. British Journal of Cancer 2003; 88: 167-174.

23. Emri S. Recent developments in the therapy of malignnat pleural mesothelioma. Indoor and Built Environment 2003;12:391-393(review)

24. Vogelzang NJ, Rusthoven J, Paoletti P, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer MJ, Emri S, Niyikiza C. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-2644.

25. Emri S, Demir AU. Malignant pleural mesothelioma in Turkey, 2000-2002. Lung Cancer 2004;455: S17-S20.

26. Aslan D, Altıntaş H, Emri S, et al. Self-evaluations of tuberculosis patients about their illnesses at Ankara Ataturk Sanatorium Training and Research Hospital, Turkey. Respir Med 2004;98:626-631.

27. Kokturk N, Firat P, Akay H, Kadilar C, Ozturk C, Zorlu F, Gungen Y, Emri S. Prognostic significance of Bax and Fas Ligand in erionite and asbestos induced Turkish malignant plural mesothelioma. Lung Cancer 2005;50:189-198.

28. Dogan AU, Baris YI, Dogan M, Emri S, steele I, Elmishad AG, Carbone M. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 2006;66:5063-5068.

29. Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, Baris YI. A mesothelioma epidemic in Cappadocia:scientific developments and unexpected social outcomes. Nat Rev Cancer 2007; 2:147-154. Review.

30. Zorlu Af, Selek U, Emri S. Gurkaynak M, Akyol FH. Second line palliative endobronchial radiotherapy with HDR Ir 192 in recurrent lung carcinoma. Yonsei Med J 2008; 49: 620-624.
31. Hurmuz P, akyol F, Selek U, Ozyigit G, Dogan R, Ozdemir N, Tastepe I, Cangir AK, Kara M, Demirkazik FB, Emri S. The efficiency and toxicitiy of hemithoracic radiotherapy after extra pleural pneumonectomy in malignant pleural mesothelioma. UHOD 2010;20:20-26.

32 .Bacanli S , Icen D , Emri S . Fuzzy approach of group sequential test for binomial case.
HACETTEPE JOURNAL OF MATHEMATICS AND STATISTICS, Volume: 43, Issue: 6 Pages: 1017-1034, 2014.

33.Emri S, Kilickap S, Kadilar C, Halil MG, Akay H, Besler T. Serum levels of alpha-tocopherol, vitamin C, beta-carotene, and retinol in malignant pleural mesothelioma. Asian Pac J Cancer Prev. 2012;13(7):3025-9.

34. Onder S, Guler G, Emri S, Fırat P. EGFR expression and gene copy number in malignant pleuraş mesothelioma in Turkey. UHOD-Uluslararası Hematoloji Onkoloji Dergisi 2012;22(3): 181-186.

35. Ybarra M, Bağci Bosi AT, Korchmaros J, Emri S. Correction: A Text Messaging-Based Smoking Cessation Program for Adult Smokers: Randomized Controlled Trial. J Med Internet Res. 2015 Jun 5;17(6):e125. doi: 10.2196/jmir.4655

36. Er M, Emri SA, Demir AU, Thorne PS, Karakoca Y, Bilir N, Barış Yİ. Byssinosis and COPD rates among factory workers manufacturing hemp and jute. Int J Occup Med Environ Health 2016;29(1):55–68 DOI: 10.13075/ijomeh.1896.00512.

37. Ozturk O, Sandal A, Karahan S, Er B, Onder S, Koksal D, Maden E, Emri S. Diagnostic yield of conventional transbronchial needle aspirat,on biopsy(C-TBNA) withoutan on site cytopathologist: Experience of 363 procedures in 219 patients.TUBERCULOSIS AND THORAX 2016,64:137-143,doı: 10.5578/TT.10905